Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Hart

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Cellular Immunology|September 20, 2005
Eighth Leucocyte Differentiation Antigen Workshop DC section summaryGeorgina Clark, David Munster, Shakeel Yusuf, et al.
Cytotherapy|June 19, 2004
DC preparations for therapyA M Rice, K L Jones, D N J Hart
Trends in Immunology|April 11, 2009
The CD300 family of molecules are evolutionarily significant regulators of leukocyte functionsGeorgina J Clark, Xinsheng Ju, Courtney Tate, et al.
Transplantation|August 2, 2013
Alterations in chemokine receptor CCR5 expression on blood dendritic cells correlate with acute graft-versus-host diseaseKifah Shahin, Mary Sartor, Derek N J Hart, et al.
Blood|June 7, 2008
CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligandsXinsheng Ju, Martin Zenke, Derek N J Hart, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Monocytes immunoselected via the novel monocyte specific molecule, CD300e, differentiate into active migratory dendritic cellsGeorgina J Clark, Lubomira Jamriska, Min Rao, et al.
Journal of Leukocyte Biology|August 19, 2007
Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expressionGeorgina J Clark, Min Rao, Xinsheng Ju, et al.
Advances in Cancer Research|November 27, 2007
Dendritic cells in cancer immunotherapyAnnelie Vulink, Kristen J Radford, Cornelis Melief, et al.
Stem Cells and Development|November 15, 2007
Cord blood CD34+ cells cultured with FLT3L, stem cell factor, interleukin-6, and IL-3 produce CD11c+CD1a-/c- myeloid dendritic cellsS A W Fadilah, S Vuckovic, D Khalil, et al.
Pathology|September 8, 2011
Cellular therapy to treat haematological and other malignancies: progress and pitfallsPhillip D Fromm, David Gottlieb, Kenneth F Bradstock, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Cellular Immunology|September 20, 2005
Eighth Leucocyte Differentiation Antigen Workshop DC section summaryGeorgina Clark, David Munster, Shakeel Yusuf, et al.
Cytotherapy|June 19, 2004
DC preparations for therapyA M Rice, K L Jones, D N J Hart
Trends in Immunology|April 11, 2009
The CD300 family of molecules are evolutionarily significant regulators of leukocyte functionsGeorgina J Clark, Xinsheng Ju, Courtney Tate, et al.
Transplantation|August 2, 2013
Alterations in chemokine receptor CCR5 expression on blood dendritic cells correlate with acute graft-versus-host diseaseKifah Shahin, Mary Sartor, Derek N J Hart, et al.
Blood|June 7, 2008
CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligandsXinsheng Ju, Martin Zenke, Derek N J Hart, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Monocytes immunoselected via the novel monocyte specific molecule, CD300e, differentiate into active migratory dendritic cellsGeorgina J Clark, Lubomira Jamriska, Min Rao, et al.
Journal of Leukocyte Biology|August 19, 2007
Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expressionGeorgina J Clark, Min Rao, Xinsheng Ju, et al.
Advances in Cancer Research|November 27, 2007
Dendritic cells in cancer immunotherapyAnnelie Vulink, Kristen J Radford, Cornelis Melief, et al.
Stem Cells and Development|November 15, 2007
Cord blood CD34+ cells cultured with FLT3L, stem cell factor, interleukin-6, and IL-3 produce CD11c+CD1a-/c- myeloid dendritic cellsS A W Fadilah, S Vuckovic, D Khalil, et al.
Pathology|September 8, 2011
Cellular therapy to treat haematological and other malignancies: progress and pitfallsPhillip D Fromm, David Gottlieb, Kenneth F Bradstock, et al.
Pageof 9